Epigenetic silencing of WNT5A in Epstein-Barr virus-associated gastric carcinoma

Archives of Virology

Volumn 158, Issue 1, 2013, Pages 123-132

  Liu, Xia ^a   Wang, Yun ^a   Wang, Xiaofeng ^a   Sun, Zhifu ^b   Li, Lili ^c,d   Tao, Qian ^c,d   Luo, Bing ^a  

^a QINGDAO UNIVERSITY MEDICAL COLLEGE   (China)

^b MAYO CLINIC   (United States)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^d SHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN HERPESVIRUS 4;

EID: 84872263647     PISSN: 03048608     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00705-012-1481-x     Document Type: Article

References (32)

1. Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55(2): 74-108. doi: 55/2/74.
2. Crawford DH (2001) Biology and disease associations of Epstein-Barr virus. Philos Trans R Soc Lond B Biol Sci 356(1408): 461-473. doi: 10. 1098/rstb. 2000. 0783.
3. Takada K (2000) Epstein-Barr virus and gastric carcinoma. Mol Pathol 53(5): 255-261.
4. Imai S, Koizumi S, Sugiura M, Tokunaga M, Uemura Y, Yamamoto N, Tanaka S, Sato E, Osato T (1994) Gastric carcinoma: monoclonal epithelial malignant cells expressing Epstein-Barr virus latent infection protein. Proc Natl Acad Sci USA 91(19): 9131-9135.
5. Sugiura M, Imai S, Tokunaga M, Koizumi S, Uchizawa M, Okamoto K, Osato T (1996) Transcriptional analysis of Epstein-Barr virus gene expression in EBV-positive gastric carcinoma: unique viral latency in the tumour cells. Br J Cancer 74(4): 625-631.
6. Chen JN, He D, Tang F, Shao CK (2012) Epstein-Barr virus-associated gastric carcinoma: a newly defined entity. J Clin Gastroenterol 46(4): 262-271. doi: 10. 1097/MCG. 0b013e318249c4b8.
7. Sakuma K, Chong JM, Sudo M, Ushiku T, Inoue Y, Shibahara J, Uozaki H, Nagai H, Fukayama M (2004) High-density methylation of p14ARF and p16INK4A in Epstein-Barr virus-associated gastric carcinoma. Int J Cancer 112(2): 273-278. doi: 10. 1002/ijc. 20420.
8. Sudo M, Chong JM, Sakuma K, Ushiku T, Uozaki H, Nagai H, Funata N, Matsumoto Y, Fukayama M (2004) Promoter hypermethylation of E-cadherin and its abnormal expression in Epstein-Barr virus-associated gastric carcinoma. Int J Cancer 109(2): 194-199. doi: 10. 1002/ijc. 11701.
9. Da Forno PD, Pringle JH, Hutchinson P, Osborn J, Huang Q, Potter L, Hancox RA, Fletcher A, Saldanha GS (2008) WNT5A expression increases during melanoma progression and correlates with outcome. Clin Cancer Res 14(18): 5825-5832. doi: 10. 1158/1078-0432. CCR-07-5104.
10. Ripka S, Konig A, Buchholz M, Wagner M, Sipos B, Kloppel G, Downward J, Gress T, Michl P (2007) WNT5A-target of CUTL1 and potent modulator of tumor cell migration and invasion in pancreatic cancer. Carcinogenesis 28(6): 1178-1187. doi: 10. 1093/carcin/bgl255.
11. Huang CL, Liu D, Nakano J, Ishikawa S, Kontani K, Yokomise H, Ueno M (2005) Wnt5a expression is associated with the tumor proliferation and the stromal vascular endothelial growth factor-an expression in non-small-cell lung cancer. J Clin Oncol 23(34): 8765-8773. doi: 10. 1200/JCO. 2005. 02. 2871.
12. Wang Q, Williamson M, Bott S, Brookman-Amissah N, Freeman A, Nariculam J, Hubank MJ, Ahmed A, Masters JR (2007) Hypomethylation of WNT5A, CRIP1 and S100P in prostate cancer. Oncogene 26(45): 6560-6565. doi: 10. 1038/sj. onc. 1210472.
13. Dejmek J, Dejmek A, Safholm A, Sjolander A, Andersson T (2005) Wnt-5a protein expression in primary dukes B colon cancers identifies a subgroup of patients with good prognosis. Cancer Res 65(20): 9142-9146. doi: 10. 1158/0008-5472. CAN-05-1710.
14. Blanc E, Roux GL, Benard J, Raguenez G (2005) Low expression of Wnt-5a gene is associated with high-risk neuroblastoma. Oncogene 24(7): 1277-1283. doi: 10. 1038/sj. onc. 1208255.
15. Jonsson M, Dejmek J, Bendahl PO, Andersson T (2002) Loss of Wnt-5a protein is associated with early relapse in invasive ductal breast carcinomas. Cancer Res 62(2): 409-416.
16. Liang H, Chen Q, Coles AH, Anderson SJ, Pihan G, Bradley A, Gerstein R, Jurecic R, Jones SN (2003) Wnt5a inhibits B cell proliferation and functions as a tumor suppressor in hematopoietic tissue. Cancer Cell 4(5): 349-360. doi: S153561080300268X.
17. Shackelford J, Maier C, Pagano JS (2003) Epstein-Barr virus activates beta-catenin in type III latently infected B lymphocyte lines: association with deubiquitinating enzymes. Proc Natl Acad Sci USA 100(26): 15572-15576. doi: 10. 1073/pnas. 26369471002636947100.
18. Morrison JA, Raab-Traub N (2005) Roles of the ITAM and PY motifs of Epstein-Barr virus latent membrane protein 2A in the inhibition of epithelial cell differentiation and activation of {beta}-catenin signaling. J Virol 79(4): 2375-2382. doi: 10. 1128/JVI. 79. 4. 2375-2382. 2005.
19. Everly DN Jr, Kusano S, Raab-Traub N (2004) Accumulation of cytoplasmic beta-catenin and nuclear glycogen synthase kinase 3beta in Epstein-Barr virus-infected cells. J Virol 78(21): 11648-11655. doi: 10. 1128/JVI. 78. 21. 11648-11655. 2004.
20. Morrison JA, Klingelhutz AJ, Raab-Traub N (2003) Epstein-Barr virus latent membrane protein 2A activates beta-catenin signaling in epithelial cells. J Virol 77(22): 12276-12284.
21. Ying J, Li H, Yu J, Ng KM, Poon FF, Wong SC, Chan AT, Sung JJ, Tao Q (2008) WNT5A exhibits tumor-suppressive activity through antagonizing the Wnt/beta-catenin signaling, and is frequently methylated in colorectal cancer. Clin Cancer Res 14(1): 55-61. doi: 10. 1158/1078-0432. CCR-07-1644.
22. Li J, Ying J, Fan Y, Wu L, Ying Y, Chan AT, Srivastava G, Tao Q (2010) WNT5A antagonizes WNT/beta-catenin signaling and is frequently silenced by promoter CpG methylation in esophageal squamous cell carcinoma. Cancer Biol Ther 10(6): 617-624. doi: 12609.
23. Wang Y, Kanai K, Satoh Y, Luo B, Sairenji T (2007) Carboxyl-terminal sequence variation of latent membrane protein 1 gene in Epstein-Barr virus-associated gastric carcinomas from Eastern China and Japan. Intervirology 50(3): 229-236. doi: 10. 1159/000100566.
24. Ying J, Srivastava G, Hsieh WS, Gao Z, Murray P, Liao SK, Ambinder R, Tao Q (2005) The stress-responsive gene GADD45G is a functional tumor suppressor, with its response to environmental stresses frequently disrupted epigenetically in multiple tumors. Clin Cancer Res 11(18): 6442-6449. doi: 10. 1158/1078-0432. CCR-05-0267.
25. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25(4): 402-408. doi: 10. 1006/meth. 2001. 1262.
26. Kurayoshi M, Oue N, Yamamoto H, Kishida M, Inoue A, Asahara T, Yasui W, Kikuchi A (2006) Expression of Wnt-5a is correlated with aggressiveness of gastric cancer by stimulating cell migration and invasion. Cancer Res 66(21): 10439-10448. doi: 10. 1158/0008-5472. CAN-06-2359.
27. Yang X, Noushmehr H, Han H, Andreu-Vieyra C, Liang G, Jones PA (2012) Gene reactivation by 5-aza-2′-deoxycytidine-induced demethylation requires SRCAP-mediated H2A. Z insertion to establish nucleosome depleted regions. PLoS Genet 8 (3): e1002604. doi: 10. 1371/journal. pgen. 1002604.
28. Person AD, Beiraghi S, Sieben CM, Hermanson S, Neumann AN, Robu ME, Schleiffarth JR, Billington CJ Jr, van Bokhoven H, Hoogeboom JM, Mazzeu JF, Petryk A, Schimmenti LA, Brunner HG, Ekker SC, Lohr JL (2010) WNT5A mutations in patients with autosomal dominant Robinow syndrome. Dev Dyn 239(1): 327-337. doi: 10. 1002/dvdy. 22156.
29. Liu K, Wang YF, Cantemir C, Muller MT (2003) Endogenous assays of DNA methyltransferases: Evidence for differential activities of DNMT1, DNMT2, and DNMT3 in mammalian cells in vivo. Mol Cell Biol 23(8): 2709-2719.
30. Hino R, Uozaki H, Murakami N, Ushiku T, Shinozaki A, Ishikawa S, Morikawa T, Nakaya T, Sakatani T, Takada K, Fukayama M (2009) Activation of DNA methyltransferase 1 by EBV latent membrane protein 2A leads to promoter hypermethylation of PTEN gene in gastric carcinoma. Cancer Res 69(7): 2766-2774. doi: 10. 1158/0008-5472. CAN-08-3070.
31. Webb N, Connolly G, Tellam J, Yap AS, Khanna R (2008) Epstein-Barr virus associated modulation of Wnt pathway is not dependent on latent membrane protein-1. PLoS One 3(9): e3254. doi: 10. 1371/journal. pone. 0003254.
32. McDonald SL, Silver A (2009) The opposing roles of Wnt-5a in cancer. Br J Cancer 101(2): 209-214. doi: 10. 1038/sj. bjc. 6605174.